180 likes | 1.04k Views
THE NATIONAL INFLUENZA VACCINE SUMMIT: UPDATE. Raymond A. Strikas, M.D. Immunization Services Division National Immunization Program Coordinating Center for Infectious Diseases Centers for Disease Control and Prevention Department of Health and Human Services NVAC Meeting – Washington, D.C.
E N D
THE NATIONAL INFLUENZA VACCINE SUMMIT: UPDATE Raymond A. Strikas, M.D. Immunization Services DivisionNational Immunization Program Coordinating Center for Infectious Diseases Centers for Disease Control and Prevention Department of Health and Human Services NVAC Meeting – Washington, D.C. June 7, 2005
(Brief) History of the National Influenza Vaccine Summit • Summit conceived in response to delays in influenza vaccine production and distribution in 2000 • Co-sponsored by AMA and CDC • 1st two Summits:March and August 2001 • Annual meetings 2002-4 • Most recent meeting May 10-11, 2005
The Summit is . . . • An annual meeting • A concept • An informal, action-oriented organization • A resource
Composition of the Summit (1) • Vaccine Manufacturers • Vaccine Distributors • Federal Agencies • Professional Medical Organizations • Nursing Organizations • Public Health • Hospitals • Pharmacists
Composition of the Summit (2) • Community Immunization Providers • Occupational Health Providers • Business • Private Health Insurance and Managed Care • Long-term Care • Quality Improvement Organizations • Consumers • Advocacy Groups
Summit Working Groups (1) • Community-based Vaccination Providers • Occupational Vaccination Providers • Payment Issues • Vaccine Distribution • Consumer Education
Summit Working Groups (2) • Vaccine Reallocation • Physicians’ Issues • Communications • Long-term Care • Executive Committee • Universal immunization (pending development)
2005 Summit Participation • 60 organizations • 154 individuals
THE 2005 NATIONAL INFLUENZA VACCINE SUMMIT:Themes and Recommendations
2005 Summit Themes • Lack of knowledge, indifference, and/or frustration in the general public, priority persons, health care providers • Stability of influenza vaccine supply • Crisis planning (focus on vaccine supply and pandemic influenza)
Results of Theme Breakout Sessions – Theme I • Avoid tiered or staggered vaccination recommendations • If tiered recommendations necessary, open vaccination to all as soon as possible • Vaccination recommendations should be clear, consistent, and clearly communicated to partners and the public • Live attenuated vaccine recommendations should be clearly distinguished from those for inactivated vaccine
Results of Theme Breakout Sessions – Theme I (continued) • Work towards policy changes encouraging/requiring health care worker (HCW) vaccination with professional groups, JCAHO, CMS • Publish HCW vaccination rates by institution
Theme II Results/Recommendations • Request vaccine pre-booking data from vaccine companies, distributors for state public health authorities • Participate in federal government working group planning for 2005-06
Theme II – Results/Recommendations (continued) • Form Universal Immunization working group to consult with ACIP • Objectives • Ensure equity • Ensure proper health infrastructure
Theme II – Results/Recommendations (continued) • Universal Immunization: • Activities may include • Write a “White Paper” • Engage health insurers • Assess • Vaccination impact • Cost effectiveness • Expand vaccination season • Identify, employ additional strategies for specific populations, e.g., children • Increase research: better vaccines, technology for administration
Theme III Results/Recommendations • Crisis: 30 million doses of vaccine available • Use antigen-sparing vaccination • Close schools, day care settings • Identify all long-term care settings (LTC), including assisted living, to facilitate vaccine delivery • Close LTC to outside visitors • Import vaccine if possible – use method other than IND
Theme III Results/Recommendations (continued) • Crisis: Pandemic Influenza • Consider Summit meeting on pandemic influenza, specifically vaccine purchase, distribution, administration: • Discuss and promote an active government role in vaccine acquisition • Promote open and direct private - public sector communication and collaboration to guarantee a rapid and equitable vaccine allocation and distribution • Promote transparent allocation of vaccine based on need (priority) • Promote the development of local capacity for vaccine allocation and distribution to priority groups • Promote local leadership and active role in vaccine allocation and distribution
A Vision of theFuture of the NationalInfluenza Vaccine Summit • Remains a permanent but informal organization at the national level • Works year-round on the issues • Flexible—can respond to contingencies • Member survey to evaluate future directions for the Summit • Could expand attention to broader array of adult vaccination issues